Drug Shortage Report for DEXAMETHASONE-OMEGA

Last updated on 2024-12-05 History
Report ID 240175
Drug Identification Number 02204266
Brand name DEXAMETHASONE-OMEGA
Common or Proper name DEXAMETHASONE SODIUM PHOSPHATE INJECTION 4MG/ML
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE PHOSPHATE
Strength(s) 4MG
Dosage form(s) LIQUID
Route of administration SOFT TISSUE INJECTION INTRAVENOUS INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR SOFT TISSUE INJECTION INTRAVENOUS INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR
Packaging size 10 x 1mL vial / fiole
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-10-15
Estimated end date 2024-12-09
Actual end date 2024-12-04
Shortage status Resolved
Updated date 2024-12-05
Company comments Product still available at CPDN Vaughan and Delta
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2024-12-05 English Compare
v7 2024-12-04 French Compare
v6 2024-12-04 English Compare
v5 2024-12-03 French Compare
v4 2024-12-03 English Compare
v3 2024-10-16 English Compare
v2 2024-10-15 French Compare
v1 2024-10-15 English Compare

Showing 1 to 8 of 8